Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2025-12-25 @ 4:31 PM
NCT ID: NCT03180957
Description: No related grade 3+ AEs were reported during the follow-up for this trial
Frequency Threshold: 5
Time Frame: Adverse events were collected from consent until 28 days after the last injection of trial, which was administered about 9 months from baseline. Therefore, adverse events were collected over approximately 10 months from baseline
Study: NCT03180957
Study Brief: Repurposing Anti-TNF for Treating Dupuytren's Disease
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Saline Saline 0 None 1 70 9 70 View
Anti-TNF Adalimumab Adalimumab 0 None 0 70 9 70 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pericarditis SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Adverse Events SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Adverse event SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View